PROCEPT BioRobotics (PRCT) Liabilities and Shareholders Equity (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $479.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 6.57% year-over-year to $479.4 million in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 2.34% increase from a year earlier, with the FY2025 full-year figure at $508.1 million, down 4.86% from the prior year.
• Liabilities and Shareholders Equity was $479.4 million for Q2 2026 at PROCEPT BioRobotics, down from $487.1 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $534.0 million in Q4 2024 and troughed at $272.4 million in Q2 2023.
• A 5-year average of $407.3 million and a median of $393.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity slipped 12.38% in 2023 and surged 37.4% in 2024, its largest moves.
• Over 5 years, Liabilities and Shareholders Equity stood at $309.3 million in 2022, then surged by 30.84% to $404.7 million in 2023, then surged by 31.95% to $534.0 million in 2024, then declined by 4.86% to $508.1 million in 2025, then slipped by 5.65% to $479.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $479.4 million (Q2 2026), $487.1 million (Q1 2026), and $508.1 million (Q4 2025), per Business Quant data.